Key facts
- This page summarizes Gregg C. Johnson's Form 3 filing for Vivos Therapeutics, Inc. (VVOS).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Feb 2026, 20:36.
Gregg C. Johnson - 04 Feb 2026 Form 3 Insider Report for Vivos Therapeutics, Inc. (VVOS)
- Reporting relationship
- Director
- Issuer ticker
- VVOS
- Reported as of
- 04 Feb 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 13 Feb 2026, 20:36:30 UTC
- Prior SEC filing
- 15 Oct 2025
- Next SEC filing
- 24 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gregg C.E. Johnson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gregg C. Johnson filed Form 3 for Vivos Therapeutics, Inc. (VVOS) on 13 Feb 2026.
Change
- Previous filing in this sequence was filed on 15 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001135957
Primary reporting owner
JOHNSON GREGG C
- Relationship
- Director
- Address
- 6081 W PARK AVE, CHANDLER
- Signature
- /s/ Gregg C.E. Johnson
- Signature date
- 13 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VVOS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,997
- Date
- 04 Feb 2026
- Ownership
- By Spite Family Holdings LP
* marks a reported price that did not pass the local price check.